MAPT and Alzheimer disease: Another OGA inhibitor, PUGNAc, reduced tau phosphorylation in PC12 cells overexpressing human tau [10], and Thiamet-G, OGA inhibitor, also considerably decreased tau aggregation and prevented neuronal cell loss in vivo in tauopathy JNPL3 mice and 3×Tg-AD mouse model [71].